IDL Diagnostics attended the European Association of Urology (EAU) 2026 conference in London last week. We had valuable discussions with physicians who use our diagnostic biomarkers in clinical practice and research.
A big thank you to everyone we met at EAU26! We received many insightful inputs that will guide our ongoing development and help us stay focused on what matters most: delivering better, faster, and more accessible diagnostics for patients.
We had the pleasure of welcoming our long-term partner Beckman Coulter Diagnostics this week for valuable discussions on the continued sales and market development for our IRMA and ELISA portfolio. Their strong market presence and ability to effectively navigate a...
In the beginning of May, IDL Diagnostics team visited our distributors in Indonesia and the Philippines as part of our ongoing efforts to strengthen local partnerships and stay closely connected to our markets. During our time in Jakarta, we had an in-depth discussion...
In the interview, Gustav Sten talks about his new role, his journey within the company, and reflects on the development under Anders Hultman’s leadership. He also shares his priorities going forward, with a focus on commercialization and continued growth.
